Prospective analysis of the use of OnabotulinumtoxinA (BOTOX) in the treatment of chronic migraine; real-life data in 254 patients from Hull, UK

BACKGROUND: Chronic migraine affects 2% of the population. It results in substantial disability and reduced quality of life. Medications used for prophylaxis in episodic migraine may also work in chronic migraine. The efficacy and safety of OnabotulinumtoxinA (BOTOX) in adults with chronic migraine...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Khalil, Modar, Zafar, Hassan W, Quarshie, Victoria, Ahmed, Fayyaz
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Springer 2014
विषय:
Research Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4166400/
https://ncbi.nlm.nih.gov/pubmed/25178393
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1129-2377-15-54
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन